ENMD Financial Facts

Dividends on Series A convertible preferred stock: 0
Research and development: 793.84K
See Full Income Statement

Total current liabilities: 565.17K
Accumulated deficit: -399.07M
See Full Balance Sheet

EntreMed Inc. (ENMD) Earnings

  |   Expand Research on ENMD
Next EPS Date 5/16/14 *Est. EPS Growth Rate -150.0% *Last Qtr.
Average EPS % Beat Rate 0.0% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS +0.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
3/21/14 Q413 -$0.05N/A N/A N/A$669.3K N/A -5.9% Details
11/14/13 Q313 -$0.05-$0.05 $0.00N/AN/A N/A +19.9% Details
8/14/13 Q213 -$0.07N/A N/A N/AN/A N/A -1% Details
5/15/13 Q113 -$0.05N/A N/A N/AN/A N/A +1.6% Details
3/21/13 Q412 -$0.02N/A N/A $669.31K$1.93M N/A -15.4% Details
11/14/12 Q312 -$0.05N/A N/A N/AN/A N/A +27% Details
8/14/12 Q212 -$0.56N/A N/A N/AN/A N/A -7.7% Details
5/15/12 Q112 -$0.23N/A N/A N/AN/A N/A +16.3% Details